Latest Articles

Publication Date
Women with endometriosis at higher risk of immune conditions, study finds - This Is Oxfordshire

Women with endometriosis at higher risk of immune conditions, study finds This Is Oxfordshire

Published: May 2, 2025, 4 a.m.
Grey’s Anatomy Recap: Daddy Issues - Vulture

Grey’s Anatomy Recap: Daddy Issues Vulture

Published: May 2, 2025, 3 a.m.
Grey’s Recap: A Romantic Twist, a Devastating Turn and One Big Step Toward a New Couple - TVLine

Grey’s Recap: A Romantic Twist, a Devastating Turn and One Big Step Toward a New Couple TVLine

Published: May 2, 2025, 3 a.m.
Endometriosis Raises Risk of Premature Menopause, Study Finds - Medical Dialogues

Endometriosis Raises Risk of Premature Menopause, Study Finds Medical Dialogues

Published: May 2, 2025, 2:45 a.m.
Watch 9News Latest Stories - Season 2025 - Election leaders make last-ditch scramble for votes across the country - 9Now

Watch 9News Latest Stories - Season 2025 - Election leaders make last-ditch scramble for votes across the country 9Now

Published: May 2, 2025, 2:17 a.m.
Endometriosis linked to premature and early menopause - NZ Doctor

Endometriosis linked to premature and early menopause NZ Doctor

Published: May 2, 2025, 1:09 a.m.
Little-known Endometriosis symptoms as new pill approved on NHS - Daily Express

Little-known Endometriosis symptoms as new pill approved on NHS Daily Express

Published: May 2, 2025, 12:30 a.m.
Endometriosis signs and symptoms as new pill approved for painful condition - Surrey Live

Endometriosis signs and symptoms as new pill approved for painful condition Surrey Live

Published: May 2, 2025, 12:22 a.m.
I Knew My Body, But It Took a Decade for Doctors to Believe Me - BlackDoctor.org

I Knew My Body, But It Took a Decade for Doctors to Believe Me BlackDoctor.org

Published: May 2, 2025, 12:11 a.m.
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.

To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis.

Published: May 2, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!